In TCGA data, the expression level of MS4A4A, MS4A4E, MS4A6A, MS4A7, TMEM176A, and TMEM176B in 1p/19q non-codel glioma was elevated (Figure 2C). This evidence concerns the gene MS4A7 and central nervous system cancer.